Floatz logo

SIMOLADAGENE AUTOTEMCEL LENTIVIRAL VECTOR

Adenosine Deaminase Deficiency

University of California, Los Angelesgene_therapyActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Adenosine Deaminase Deficiency cohort.

Asset / SponsorPhaseRating
ELAPEGADEMASE
Leadiant Biosciences, Inc.
Phase 3BB
Adagen
Leadiant Biosciences, Inc.
Phase 3BB
Busulphan
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 1/2CCC
Infusion Of Autologous Efs-Ada Lv Cd34+ Cells
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 1/2CCC
Peg-Ada
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 1/2CCC
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 1CC

Same molecule, other indications

SIMOLADAGENE AUTOTEMCEL LENTIVIRAL VECTOR is also rated in:

severe combined immunodeficiencyDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →